Ibis celebrates the first-ever application for an OTC birth control pill in the United States

Celebrating 20 years of impact: A visual chronicle of Ibis's history

Announcing the launch of Ibis's Africa Region Strategy for 2022-2025

Learn about the SAFE Study's groundbreaking findings on self-managed abortion

Check out findings from the Trust Black Women study, conducted in partnership with SisterSong

Home

Evidence, Power, and Change drive our vision:

An inclusive, just world where we all exercise our human right to a pleasurable, safe, and healthy sexual and reproductive life.

#IbisDrivesChange

Recent Publications

July 2022

Forced travel for later abortion care in the United States: Findings and recommendations

July 2022

The growing importance of self-managed and telemedicine abortion in the United States: Medically safe, but legal risk remains

July 2022

Potential impact of telemedicine for medication abortion policy and programming changes on abortion accessibility in the United States

News & Announcements

July 2022

New survey reveals difficulties accessing abortion in Indiana, foreshadows worsening harms now that Roe v. Wade is overturned

July 2022

Ibis celebrates the first-ever application for an OTC birth control pill in the United States

June 2022

Ibis responds to overturn of Roe v. Wade

Copyright © 2022 Ibis Reproductive Health. All rights reserved. Conflict of Interest Policy